Skip to main content
OpenTrials

Clinical trial condition

Dendritic Cell Sarcoma, Interdigitating

Explore clinical trials studying Dendritic Cell Sarcoma, Interdigitating. Study availability and eligibility vary by location and protocol.

228 public trials 29 recruiting studies
Refine in advanced search Browse all conditions

Dendritic Cell Sarcoma, Interdigitating trial results

Recruiting

This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma

NCT07121946

Conditions
DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Follicular Lymphoma ( FL), +18 more
Locations
  • City of Hope Duarte, California, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Memorial Sloan Kettering Cancer Center - Bergen New York, United States
View Trial Details
Recruiting

Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies

NCT06980116

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +38 more
Locations
  • LLC ARENSIA Exploratory Medicine Tbilisi, Georgia
  • IMSP Institute of Oncology, ARENSIA Exploratory Medicine Chisinau, Moldova
  • Hospital Beata Maria Ana Madrid, Spain
  • Hospital Fundación Jiménez Diaz Madrid, Spain
View Trial Details
Recruiting

CAR-T Followed by Bispecific Antibodies

NCT04889716

Conditions
DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +6 more
Locations
  • University of Nebraska Medical Center Omaha, Nebraska, United States
  • Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Recruiting

SynKIR-310 for Relapsed/Refractory B-NHL

NCT06544265

Conditions
Aggressive B-Cell Non-Hodgkin Lymphoma, B Cell Lymphoma, Blood Protein Disorders, +54 more
Locations
  • Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute Denver, Colorado, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • The University of Kansas Cancer Center Fairway, Kansas, United States
  • Rutgers Cancer Institute New Brunswick, New Jersey, United States
View Trial Details
Recruiting

DALY II Japan/MB-CART2019.1 for DLBCL

NCT07288879

Conditions
CAR T Cell Therapy, DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, +6 more
Locations
  • National Cancer Center Hospital Tokyo, Japan
  • Toranomon Hospital Tokyo, Japan
  • Juntendo University Hospital Tokyo, Japan
  • Tokyo Metropolitan Komagome Hospital Tokyo, Japan
View Trial Details

Related conditions